Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$19.52
-9.3%
$20.31
$16.21
$24.68
N/A0.918,701 shs6,692 shs
LivaNova PLC stock logo
LIVN
LivaNova
$62.10
+0.2%
$55.41
$42.75
$64.47
$3.36B0.92645,548 shs278,425 shs
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$32.96
$32.96
$20.90
$33.93
$1.14B0.22325,002 shs1,514 shs
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$177.07
$177.00
$103.67
$177.38
$16.26B1.06746,779 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
+0.04%+0.80%+5.28%+15.70%-9.58%
LivaNova PLC stock logo
LIVN
LivaNova
-0.74%-1.54%+10.94%+22.62%+31.92%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
0.00%0.00%0.00%0.00%0.00%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
1.4088 of 5 stars
1.25.00.00.03.21.71.3
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
2.33
HoldN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
2.40
Hold$66.206.60% Upside
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/A

Current Analyst Ratings

Latest GNGBY, LIVN, VAR, and NTUS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$58.00 ➝ $66.00
5/2/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$75.00 ➝ $80.00
5/1/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$72.00
3/27/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
3/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$72.00
2/26/2024
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$57.00 ➝ $61.00
2/22/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$56.00 ➝ $62.00
2/21/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$62.00 ➝ $72.00
2/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00 ➝ $70.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$3.00BN/A$1.45 per share13.44$10.53 per shareN/A
LivaNova PLC stock logo
LIVN
LivaNova
$1.19B2.84$4.17 per share14.90$23.72 per share2.62
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$473.44M2.41$2.02 per share16.34$12.44 per share2.65
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$3.17B5.13$5.07 per share34.94$22.92 per share7.73

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$227.45M$0.7924.71N/A7.09%7.69%4.50%N/A
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M-$0.60N/A18.54N/A-2.68%13.59%7.06%7/24/2024 (Estimated)
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$13.18M$0.3789.0820.99N/A2.65%10.15%7.65%N/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$269.20M$3.9160.4330.11N/A8.50%18.45%8.08%N/A

Latest GNGBY, LIVN, VAR, and NTUS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024Q1 2024
LivaNova PLC stock logo
LIVN
LivaNova
$0.45$0.73+$0.28$2.24$278.17 million$294.90 million      
4/22/2024Q1 2024
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A$0.18+$0.18$0.20N/A$722.85 million
2/21/202412/31/2023
LivaNova PLC stock logo
LIVN
LivaNova
$0.77$0.87+$0.10$1.44$287.65 million$310.10 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.241.23%N/A30.38%N/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/AN/A

Latest GNGBY, LIVN, VAR, and NTUS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/24/2024
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.41644/23/20244/24/20245/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
0.92
0.56
LivaNova PLC stock logo
LIVN
LivaNova
0.50
3.17
2.71
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/A
2.54
1.90
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/A
1.40
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
92.35%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
86.96%

Insider Ownership

CompanyInsider Ownership
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
LivaNova PLC stock logo
LIVN
LivaNova
0.19%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
1.20%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.78%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
11,082N/AN/ANot Optionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.15 million54.05 millionOptionable
Natus Medical Incorporated stock logo
NTUS
Natus Medical
1,40034.58 million34.17 millionOptionable
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
10,00091.84 millionN/AOptionable

GNGBY, LIVN, VAR, and NTUS Headlines

SourceHeadline
FDA clarifies definition of remanufacturing for medical devices needing maintenanceFDA clarifies definition of 'remanufacturing' for medical devices needing maintenance
aha.org - May 9 at 5:28 PM
Global Industrial Linear Accelerator Market Anticipated to Cross USD 5,486.4 Million Revenue Share by 2032, Driving a 6.3% CAGR GrowthGlobal Industrial Linear Accelerator Market Anticipated to Cross USD 5,486.4 Million Revenue Share by 2032, Driving a 6.3% CAGR Growth
fmiblog.com - May 8 at 11:20 AM
The Create Building gets another tenantThe Create Building gets another tenant
sussexexpress.co.uk - May 8 at 5:42 AM
2 health systems develop new virtual care platform2 health systems develop new virtual care platform
beckershospitalreview.com - May 7 at 7:41 PM
Gamma Knife Market Expected to See Impressive CAGR of 5.2% | Market.usGamma Knife Market Expected to See Impressive CAGR of 5.2% | Market.us
pharmiweb.com - May 3 at 12:11 PM
First cancer hospital in PH: ‘Quality meets affordability’First cancer hospital in PH: ‘Quality meets affordability’
msn.com - May 2 at 3:58 PM
Magnus Medical launches Saint neuromod system for major depressive disorder treatmentMagnus Medical launches Saint neuromod system for major depressive disorder treatment
massdevice.com - May 1 at 1:42 PM
Golden Shield Award presented to Ryan Varian with the City of Belpre EMSGolden Shield Award presented to Ryan Varian with the City of Belpre EMS
msn.com - April 30 at 10:42 PM
Spectrum and Hermes Medical Solutions to offer vendor-neutral softwareSpectrum and Hermes Medical Solutions to offer vendor-neutral software
msn.com - April 29 at 4:34 PM
Titan Medical gives progress report about Conavi mergerTitan Medical gives progress report about Conavi merger
therobotreport.com - April 27 at 10:16 AM
Varian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon TechnologyVarian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon Technology
prnewswire.co.uk - April 25 at 5:58 PM
The effect of using a large language model to respond to patient messagesThe effect of using a large language model to respond to patient messages
thelancet.com - April 24 at 10:26 PM
CQ Medical™ (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024CQ Medical™ (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024
prnewswire.co.uk - April 24 at 12:26 PM
Healthway Cancer Care Hospital offers world-class cancer care at affordable pricesHealthway Cancer Care Hospital offers world-class cancer care at affordable prices
businessmirror.com.ph - April 24 at 12:26 PM
Q&A: Dr. Griffin Davis, Holy Cross Health’s chief clinical officer, on restructuring to offer “a better, different way of delivering care”Q&A: Dr. Griffin Davis, Holy Cross Health’s chief clinical officer, on restructuring to offer “a better, different way of delivering care”
bizjournals.com - April 22 at 1:59 PM
DelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightDelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finanznachrichten.de - April 18 at 6:35 PM
This device treats overactive bladder without drugs or surgeryThis device treats overactive bladder without drugs or surgery
medicaldesignandoutsourcing.com - April 18 at 6:35 PM
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightGlobal Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finance.yahoo.com - April 18 at 6:35 PM
Raigmore Hospital in Scotland selects RayCareRaigmore Hospital in Scotland selects RayCare
finance.yahoo.com - April 17 at 3:14 PM
PH’s 1st dedicated cancer hospital rises in Taguig CityPH’s 1st dedicated cancer hospital rises in Taguig City
msn.com - April 15 at 10:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™
finance.yahoo.com - April 15 at 5:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarketsRobotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets
finanznachrichten.de - April 15 at 12:34 PM
Ayala cancer hospital ready to serve 10,000 patients this yearAyala cancer hospital ready to serve 10,000 patients this year
msn.com - April 11 at 2:56 PM
Global Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMIGlobal Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMI
fmiblog.com - April 8 at 6:11 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Getinge AB (publ) logo

Getinge AB (publ)

OTCMKTS:GNGBY
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
LivaNova logo

LivaNova

NASDAQ:LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Natus Medical logo

Natus Medical

NASDAQ:NTUS
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.
Varian Medical Systems logo

Varian Medical Systems

NYSE:VAR
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.